PVI
VNDA icon

Pura Vida Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

Pura Vida Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-34,400
Closed -$899K – 124
2018
Q4 		$899K Buy
+34,400
New +$809K 0.18% 56
2018
Q1 		– Sell
-300,000
Closed -$4.56M – 94
2017
Q4 		$4.56M Buy
+300,000
New +$4.45M 1.91% 21

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pura Vida Investments's VNDA Position: Q2 2016 in Review

Pura Vida Investments sold out of Vanda Pharmaceuticals (VNDA) in Q2 2016, closing a stake of 67,500 shares — an estimated $564K sold.

Pura Vida Investments first reported a position in VNDA in Q4 2014 and held it in 5 quarters. The position peaked at $3.76M in Q2 2015. 115 funds tracked by Wall St. Rank hold VNDA as of Q2 2016.

  • Pura Vida Investments reported no remaining Vanda Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Pura Vida Investments sold 67,500 Vanda Pharmaceuticals shares in Q2 2016, an estimated $564K.
  • Pura Vida Investments first reported a position in Vanda Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Pura Vida Investments's Vanda Pharmaceuticals position peaked at $3.76M in Q2 2015.
  • 115 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2016.

Based on Pura Vida Investments's 13F filing for Q2 2016, filed 15 Aug 2016.